MASS
908 Devices Inc.NASDAQHealthcare$6.61+6.44%ClosedMarket Cap: $247.1M
As of 2026-04-06
Valuation
P/E (TTM)
12.68
PEG
0.10
P/B
1.73
P/S
4.56
EV/EBITDA
-6.24
DCF Value
$-7.75
FCF Yield
-9.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
50.6%
Operating Margin
-70.1%
Net Margin
34.7%
ROE
13.3%
ROA
10.3%
ROIC
-22.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $17.4M | 52.7% | $3.1M | $4.2M | $0.10 | — |
| FY 2025 | $56.2M | 50.6% | $-39.4M | $19.5M | $0.54 | — |
| Q3 2025 | $14.0M | 52.5% | $-16.3M | $-15.0M | $-0.41 | — |
| Q2 2025 | $13.0M | 48.9% | $-15.2M | $-13.3M | $-0.37 | — |
| Q1 2025 | $11.8M | 47.0% | $-11.0M | $43.6M | $1.23 | — |
| Q4 2024 | $18.8M | 48.7% | $-20.3M | $-19.4M | $-0.57 | — |
| FY 2024 | $59.6M | 50.2% | $-76.7M | $-72.2M | $-2.12 | — |
| Q3 2024 | $14.5M | 53.6% | $-24.5M | $-29.3M | $-0.84 | — |
| Q2 2024 | $11.5M | 53.8% | $-8.5M | $-12.5M | $-0.37 | — |
| Q1 2024 | $7.4M | 52.4% | $-7.6M | $-10.9M | $-0.33 | — |
| Q4 2023 | $14.4M | 50.7% | $-9.7M | $-7.4M | $-0.23 | — |
| FY 2023 | $50.2M | 50.4% | $-42.8M | $-36.4M | $-1.13 | — |